cGMP Quality Award: Industry First for Intellicig
The award of a Certificate of Good Manufacturing Practice (GMP) Compliance by the UK Medicine and Healthcare products Regulatory Agency (MHRA) to CN Creative, is also great news for customers and business partners of Intellicig – the leading UK producer and supplier of high quality electronic cigarettes and nicotine preparations.
The cGMP award puts Intellicig’s manufacturing quality standards on an equal footing with those for pharmaceutical and NRT products – a first for an electronic cigarette.
This latest cGMP award is formal recognition that the organisation has a Quality Management System conforming fully to objectives and principles of EU Good Manufacturing Practice.
Customers for Intellicig Electronic Cigarettes can now be sure that the ECOpure Liquid Nicotine they use has not only been created in an ISO Class 8 Clean Room from pharmacopeia sourced ingredients, but has also been created in the UK to exacting cGMP quality management standards – well in advance of the minimum level of quality required by UK Trading Standards.
Intellicig’s UK Business Partners – a distribution channel of some 5000 pharmacies and retail outlets – can also benefit from the added reassurance that the award from the MHRA brings. This is further evidence to the marketplace that
Intellicig products are manufactured in the UK to the very highest standards of quality control. Formal MHRA recognition of cGMP compliance is a great ‘u.s.p.’ for Intellicig’s Business Partners–particularly the pharmacies – giving retailers real
confidence in the products they are stocking.
Announcing the award at Intellicig’s R&D Facility within the Bioscience Incubator at Manchester University, Company Director David Newns said:
“I’m delighted with the award. A large amount of resource in both time and money has been committed to achieve this, including employing a world-class in-house quality control department led by such a respected industry figure as Laboratory & Regulatory Manager David Lawson. It’s been a very worthwhile investment which is already delivering real benefits for Intellicig’s customers and business partners.”
Reducing the harm caused by smoking: delivering the benefits of consistent quality David Newns went on to say that: “We are already the foremost producer and supplier of high quality electronic cigarettes and nicotine preparations which provide a genuine, healthier alternative to smoking, but without the tar and many thousands of other harmful ingredients found in tobacco products. We now deliver a consistent, cost-effective product fully compliant with EU Good Manufacturing Practice. In a market of questionable quality, with many products coming in from outside the EU which barely meet minimum UK Trading Standards requirements, we are proud to be producing the first e-cig manufactured to the same exacting standard as a pharmaceutical product. Once again, Intellicig is setting the standard for the industry.”
Intellicig delivers pharmaceutical-grade nicotine using advanced electronic vaporisation technology, significantly reducing the exposure of smokers to harmful tobacco smoke.
Intellicig is a global smoking alternative now sold in 24 countries and across a number of distribution channels including 8,000 pharmacies and retail stores.
For further press information please contact PR Manager Mark Mason
E-mail:firstname.lastname@example.org or tel: 020 8567 3106 mobile: 07932 792 723
This press release was distributed by ResponseSource Press Release Wire on behalf of CN Creative in the following categories: Health, Consumer Technology, Medical & Pharmaceutical, for more information visit https://pressreleasewire.responsesource.com/about.